Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

The "Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region" report has been added to ...

A new study finds no significant differences in cardiovascular and thromboembolic risks among biologics for psoriasis or ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...